Detalhe da pesquisa
1.
Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer.
Int J Cancer
; 147(4): 1078-1085, 2020 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31840815
2.
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Lancet Oncol
; 18(9): 1159-1171, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28781171
3.
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
BMC Cancer
; 16: 339, 2016 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-27246726
4.
Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
BMC Cancer
; 15: 802, 2015 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-26503593
5.
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
BMC Cancer
; 14: 897, 2014 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25487708
6.
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.
Ann Hematol
; 93(10): 1717-24, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24824768
7.
Adequate SIRT activity dose is as important as adequate chemotherapy dose - Authors' reply.
Lancet Oncol
; 18(11): e637, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29208391
8.
Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
ANZ J Surg
; 92(11): 2961-2967, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35841184
9.
Cetuximab for the treatment of colorectal cancer.
N Engl J Med
; 357(20): 2040-8, 2007 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18003960
10.
Capecitabine as adjuvant treatment for stage III colon cancer.
N Engl J Med
; 352(26): 2696-704, 2005 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-15987918
11.
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial.
J Geriatr Oncol
; 9(1): 32-39, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28807738
12.
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.
Clin Colorectal Cancer
; 17(4): e617-e629, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30033117
13.
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.
Clin Colorectal Cancer
; 17(4): 313-319, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30463680
14.
Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
J Med Econ
; 20(2): 193-199, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27676291
15.
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.
JMIR Res Protoc
; 6(3): e43, 2017 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-28351831
16.
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
J Clin Oncol
; 34(15): 1723-31, 2016 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26903575
17.
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.
J Clin Oncol
; 34(19): 2258-64, 2016 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27114605
18.
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
Target Oncol
; 11(3): 383-400, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26706237
19.
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.
J Clin Oncol
; 20(12): 2812-23, 2002 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12065558
20.
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.
Eur J Cancer
; 51(1): 18-26, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25466509